Quarterly report [Sections 13 or 15(d)]

Consolidated Balance Sheets (Parenthetical)

v3.26.1
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Accumulated amortization of deferred leasing costs $ 45,370 $ 44,127
Common shares of beneficial interest, par value (in dollars per share) $ 0.01 $ 0.01
Common shares of beneficial interest, shares authorized (in shares) 150,000,000 150,000,000
Common shares of beneficial interest, shares issued (in shares) 113,377,523 113,210,642
Common shares of beneficial interest, shares outstanding (in shares) 113,377,523 113,210,642
Investing Receivables    
Investing receivable allowance for credit loss $ 3,253 $ 3,575